Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Unicycive Therapeutics, Inc. (UNCY) had Return on Investments of -494.27% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-37.82M |
|
-- |
|
-- |
|
$32.12M |
|
$-32.12M |
|
$-4.61M |
|
$-36.73M |
|
$-36.73M |
|
$-36.73M |
|
$-36.73M |
|
$-36.73M |
|
$-36.73M |
|
$-32.12M |
|
$-31.69M |
|
66.98M |
|
66.98M |
|
$-0.56 |
|
$-0.56 |
|
| Balance Sheet Financials | |
$30.95M |
|
$0.07M |
|
$0.72M |
|
$31.67M |
|
$24.12M |
|
-- |
|
$0.12M |
|
$24.24M |
|
$7.43M |
|
$7.43M |
|
$7.43M |
|
113.84M |
|
| Cash Flow Statement Financials | |
$-28.57M |
|
$-0.07M |
|
$45.09M |
|
$9.70M |
|
$26.14M |
|
$16.44M |
|
$2.35M |
|
$-1.09M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.28 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-28.65M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-494.27% |
|
-494.27% |
|
-115.98% |
|
|
Return on Investments |
-494.27% |
$0.07 |
|
$-0.43 |
|
$-0.43 |
|